Hydrocephalus Questions & Answers

1. Rekate HL. A contemporary definition and classification of hydrocephalus. Semin Pediatr Neurol. 2009 Mar. 16(1):9-15. [QxMD MEDLINE Link].

2. Kahlon B, Annertz M, Stahlberg F, Rehncrona S. Is aqueductal stroke volume, measured with cine phase-contrast magnetic resonance imaging scans useful in predicting outcome of shunt surgery in suspected normal pressure hydrocephalus?. Neurosurgery. 2007 Jan. 60(1):124-9; discussion 129-30. [QxMD MEDLINE Link].

3. Hattingen E, Jurcoane A, Melber J, Blasel S, Zanella FE, Neumann-Haefelin T. Diffusion tensor imaging in patients with adult chronic idiopathic hydrocephalus. Neurosurgery. 2010 May. 66(5):917-24. [QxMD MEDLINE Link].

4. Hamilton MG. Treatment of hydrocephalus in adults. Semin Pediatr Neurol. 2009 Mar. 16(1):34-41. [QxMD MEDLINE Link].

5. Kuruvilla LC. Benign enlargement of sub-arachnoid spaces in infancy. J Pediatr Neurosci. 5/9/2014. 9:129-31. [QxMD MEDLINE Link]. [Full Text].

6. Woodworth GF, McGirt MJ, Williams MA, Rigamonti D. Cerebrospinal fluid drainage and dynamics in the diagnosis of normal pressure hydrocephalus. Neurosurgery. 2009 May. 64(5):919-25; discussion 925-6. [QxMD MEDLINE Link].

7. Lacy M, Oliveira M, Austria E, Frim MD. Neurocognitive outcome after endoscopic third ventriculocisterostomy in patients with obstructive hydrocephalus. J Int Neuropsychol Soc. 2009 May. 15(3):394-8. [QxMD MEDLINE Link].

8. Garne E, Loane M, Addor MC, Boyd PA, Barisic I, Dolk H. Congenital hydrocephalus - prevalence, prenatal diagnosis and outcome of pregnancy in four European regions. Eur J Paediatr Neurol. 2009 Apr 30. [QxMD MEDLINE Link].

9. Partington MD. Congenital hydrocephalus. Neurosurg Clin N Am. 2001 Oct. 12(4):737-42, ix. [QxMD MEDLINE Link].

10. Vinchon M, Rekate HL, Kulkarni AV. Pediatric hydrocephalus outcomes: a review. Fluids Barriers CNS. 2012 Aug 27. 9(1):18. [QxMD MEDLINE Link].

11. DeBenedictis CN, Rubin SE, Kodsi SR. Esotropia in Children with Ventricular-Peritoneal Shunts. Strabismus. 2015 Sep. 23 (3):117-20. [QxMD MEDLINE Link].

12. Chauvet D, Sichez JP, Boch AL. [Early epidural hematoma after CSF shunt for obstructive hydrocephalus]. Neurochirurgie. 2009 Jun. 55(3):350-3. [QxMD MEDLINE Link].

13. Oertel JM, Mondorf Y, Baldauf J, Schroeder HW, Gaab MR. Endoscopic third ventriculostomy for obstructive hydrocephalus due to intracranial hemorrhage with intraventricular extension. J Neurosurg. 2009 May 8. [QxMD MEDLINE Link].

14. Espay AJ, Narayan RK, Duker AP, Barrett ET Jr, de Courten-Myers G. Lower-body parkinsonism: reconsidering the threshold for external lumbar drainage. Nat Clin Pract Neurol. 2008 Jan. 4(1):50-5. [QxMD MEDLINE Link].

15. [Guideline] Dormont D, Seidenwurm DJ, Davis PC. Dementia and movement disorders. American College of Radiology (ACR). 2007. [Full Text].

16. Larsson A, Moonen M, Bergh AC, Lindberg S, Wikkelso C. Predictive value of quantitative cisternography in normal pressure hydrocephalus. Acta Neurol Scand. 1990 Apr. 81(4):327-32. [QxMD MEDLINE Link].

17. Walchenbach R, Geiger E, Thomeer RT, Vanneste JA. The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2002 Apr. 72(4):503-6. [QxMD MEDLINE Link].

18. Lee JH, Back DB, Park DH, Cha YH, Kang SH, Suh JK. Increased Vascular Endothelial Growth Factor in the Ventricular Cerebrospinal Fluid as a Predictive Marker for Subsequent Ventriculoperitoneal Shunt Infection : A Comparison Study among Hydrocephalic Patients. J Korean Neurosurg Soc. 2012 Jun. 51(6):328-33. [QxMD MEDLINE Link]. [Full Text].

19. Black PML. Hydrocephalus in adults. Youmans JR, ed. Neurological Surgery. Philadelphia: WB Saunders Company; 1996. 927-44.

20. Chang CC, Kuwana N, Noji M, Tanabe Y, Koike Y, Ikegami T. Cerebral blood flow in patients with normal pressure hydrocephalus. Nucl Med Commun. 1999 Feb. 20(2):167-9. [QxMD MEDLINE Link].

21. Colak A, Albright AL, Pollack IF. Follow-up of children with shunted hydrocephalus. Pediatr Neurosurg. 1997 Oct. 27(4):208-10. [QxMD MEDLINE Link].

22. Czosnyka M, Pickard JD. Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry. 2004 Jun. 75(6):813-21. [QxMD MEDLINE Link].

23. Damasceno BP, Carelli EF, Honorato DC, Facure JJ. The predictive value of cerebrospinal fluid tap-test in normal pressure hydrocephalus. Arq Neuropsiquiatr. 1997 Jun. 55(2):179-85. [QxMD MEDLINE Link].

24. du Plessis AJ. Posthemorrhagic hydrocephalus and brain injury in the preterm infant: dilemmas in diagnosis and management. Semin Pediatr Neurol. 1998 Sep. 5(3):161-79. [QxMD MEDLINE Link].

25. Frim DM, Scott RM, Madsen JR. Surgical management of neonatal hydrocephalus. Neurosurg Clin N Am. 1998 Jan. 9(1):105-10. [QxMD MEDLINE Link].

26. Garvey MA, Laureno R. Hydrocephalus: obliterated perimesencephalic cisterns and the danger of sudden death. Can J Neurol Sci. 1998 May. 25(2):154-8. [QxMD MEDLINE Link].

27. Goumnerova LC, Frim DM. Treatment of hydrocephalus with third ventriculocisternostomy: outcome and CSF flow patterns. Pediatr Neurosurg. 1997 Sep. 27(3):149-52. [QxMD MEDLINE Link].

28. Hoppe-Hirsch E, Laroussinie F, Brunet L, et al. Late outcome of the surgical treatment of hydrocephalus. Childs Nerv Syst. 1998 Mar. 14(3):97-9. [QxMD MEDLINE Link].

29. Libenson MH, Kaye EM, Rosman NP, Gilmore HE. Acetazolamide and furosemide for posthemorrhagic hydrocephalus of the newborn. Pediatr Neurol. 1999 Mar. 20(3):185-91. [QxMD MEDLINE Link].

30. Mercuri E, Faundez JC, Cowan F, Dubowitz L. Acetazolamide without frusemide in the treatment of post-haemorrhagic hydrocephalus. Acta Paediatr. 1994 Dec. 83(12):1319-21. [QxMD MEDLINE Link].

31. Poca MA, Mataro M, Del Mar Matarin M, Arikan F, Junque C, Sahuquillo J. Is the placement of shunts in patients with idiopathic normal-pressure hydrocephalus worth the risk? Results of a study based on continuous monitoring of intracranial pressure. J Neurosurg. 2004 May. 100(5):855-66. [QxMD MEDLINE Link].

32. Sainte-Rose C. Hydrocephalus in childhood. Youmans JR, ed. Neurological Surgery. Philadelphia: WB Saunders Company; 1996. 890-926.

33. Sansone JM, Iskandar BJ. Endoscopic cerebral aqueductoplasty: a trans-fourth ventricle approach. J Neurosurg. 2005 Nov. 103(5 Suppl):388-92. [QxMD MEDLINE Link].

34. Shbeeb MI, O'Duffy JD, Michet CJ Jr, O'Fallon WM, Matteson EL. Evaluation of glucocorticosteroid injection for the treatment of trochanteric bursitis. J Rheumatol. 1996 Dec. 23(12):2104-6. [QxMD MEDLINE Link].

35. Tanaka A, Kimura M, Nakayama Y, Yoshinaga S, Tomonaga M. Cerebral blood flow and autoregulation in normal pressure hydrocephalus. Neurosurgery. 1997 Jun. 40(6):1161-5; discussion 1165-7. [QxMD MEDLINE Link].

36. Vogel TW, Bahuleyan B, Robinson S, Cohen AR. The role of endoscopic third ventriculostomy in the treatment of hydrocephalus. J Neurosurg Pediatr. 2013 Jul. 12(1):54-61. [QxMD MEDLINE Link].

37. Williams MA, Razumovsky AY, Hanley DF. Comparison of Pcsf monitoring and controlled CSF drainage diagnose normal pressure hydrocephalus. Acta Neurochir Suppl. 1998. 71:328-30. [QxMD MEDLINE Link].

Stephen L Nelson, Jr, MD, PhD, FAACPDM, FAAN, FAAP, FANA Professor of Pediatrics, Neurology, Neurosurgery, and Psychiatry, Medical Director, Tulane Center for Autism and Related Disorders, Tulane University School of Medicine; Pediatric Neurologist and Epileptologist, Ochsner Hospital for Children; Professor of Neurology, Louisiana State University School of Medicine

Stephen L Nelson, Jr, MD, PhD, FAACPDM, FAAN, FAAP, FANA is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Neurology, American Academy of Pediatrics, American Epilepsy Society, American Medical Association, American Neurological Association, The Society of Federal Health Professionals (AMSUS), Child Neurology Society, Southern Pediatric Neurology Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Jasvinder Chawla, MD, MBA Chief of Neurology, Hines Veterans Affairs Hospital; Professor of Neurology, Loyola University Medical Center

Jasvinder Chawla, MD, MBA is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Clinical Neurophysiology Society, American Medical Association

Disclosure: Nothing to disclose.

Anthony M Murro, MD Professor, Laboratory Director, Department of Neurology, Medical College of Georgia, Georgia Regents University

Anthony M Murro, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society

Disclosure: Nothing to disclose.

Alberto J Espay, MD, MSc Associate Professor, Director of Clinical Research, Gardner Family Center for Parkinson's Disease and Movement Disorders, University of Cincinnati College of Medicine

Alberto J Espay, MD, MSc is a member of the following medical societies: American Academy of Neurology and Movement Disorders Society

Disclosure: Abbott Consulting fee Consulting; Chelsea therapeutics Consulting fee Consulting; Novartis Honoraria Speaking and teaching; TEVA Consulting fee Consulting; NIH Grant/research funds K23 Career Development Award; Eli Lilly Consulting fee Consulting; Great Lakes Neurotechnologies Other; Michael J Fox Foundation Grant/research funds Other; Lippincott Williams & Wilkins Royalty Book; American Academy of Neurology Honoraria Speaking and teaching

Eugenia-Daniela Hord, MD Instructor, Departments of Anesthesia and Neurology, Massachusetts General Hospital Pain Center, Harvard Medical School

Eugenia-Daniela Hord, MD is a member of the following medical societies: American Academy of Neurology and American Pain Society

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article